文献速递临床微生物分子诊断

全基因组测序数据用于下呼吸道感染分离株的物种鉴定与耐药预测:ARESdb分析

Species Identification and Antibiotic Resistance Prediction by Analysis of Whole-Genome Sequence Data by Use of ARESdb: an Analysis of Isolates from the Unyvero Lower Respiratory Tract Infection Trial.
PubMed 文献 · J Clin Microbiol · 2020-06-24

该研究对Unyvero下呼吸道感染试验中455份培养阳性样本的620株临床分离株进行全基因组测序,用开源工具鉴定物种、ARESdb预测药敏,并与MALDI-TOF MS鉴定和肉汤微量稀释表型药敏比较。WGS在属和种水平与MALDI-TOF MS的一致率分别为99%和93%;在129个物种-化合物对中,WGS预测药敏与表型药敏的类别一致率为89%,其中78对超过90%,32对达100%。

要点

  • WGS物种鉴定与MALDI-TOF MS在属水平一致率99%,种水平93%。
  • WGS预测药敏与表型药敏总体类别一致率89%(129个物种-化合物对)。
  • 78个物种-化合物对一致率超过90%,其中32对达100%。

核心结论

  • 随着分析工具改进,全基因组测序数据有望用于预测抗菌药物敏感性。

研究设计与样本

  • 研究基于FDA已批准的Unyvero下呼吸道感染应用的多中心临床试验,该试验从9家医院ICU采集超过2000份患者样本。
  • 本研究纳入620株临床分离株,来自455份下呼吸道感染培养阳性患者样本。
  • 分离株采用Illumina Nextera XT方案测序,原始FASTQ读长上传至ARESdb云平台进行分析。
  • WGS鉴定结果与MALDI-TOF MS比较,WGS药敏预测与肉汤微量稀释表型药敏比较。

主要发现

  • WGS鉴定与MALDI-TOF MS在属水平一致率为99%,种水平为93%。
  • WGS预测药敏与表型药敏在129个物种-化合物对中总体类别一致率为89%。
  • 78个物种-化合物对的类别一致率超过90%,其中32对达到100%。

关键数值与推荐

  • WGS鉴定与MALDI-TOF MS属水平一致率99%、种水平一致率93%。
  • WGS预测药敏与表型药敏总体类别一致率89%(129个物种-化合物对)。
  • 78个物种-化合物对类别一致率超过90%,32对达100%。

临床怎么用

  • 临床微生物实验室常规开展WGS评估分离株亲缘关系时,同一数据经适当分析可用于预测抗菌药物敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Whole-genome sequencing (WGS) is now routinely performed in clinical microbiology laboratories to assess isolate relatedness. With appropriately developed analytics, the same data can be used for prediction of antimicrobial susceptibility. We assessed WGS data for identification using open-source tools and antibiotic susceptibility testing (AST) prediction using ARESdb compared to matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) identification and broth microdilution phenotypic susceptibility testing on clinical isolates from a multicenter clinical trial of the FDA-cleared Unyvero lower respiratory tract infection (LRTI) application (Curetis). For the trial, more than 2,000 patient samples were collected from intensive care units across nine hospitals and tested for LRTI. The isolate subset used in this study included 620 clinical isolates originating from 455 LRTI culture-positive patient samples. Isolates were sequenced using the Illumina Nextera XT protocol and FASTQ files with raw reads uploaded to the ARESdb cloud platform (ares-genetics.cloud; released for research use in 2020). The platform combines Ares Genetics' proprietary database ARESdb with state-of-the-art bioinformatics tools and curated public data. For identification, WGS showed 99 and 93% concordance with MALDI-TOF MS at the genus and species levels, respectively. WGS-predicted susceptibility showed 89% categorical agreement with phenotypic susceptibility across a total of 129 species-compound pairs analyzed, with categorical agreement exceeding 90% in 78 species-compound pairs and reaching 100% in 32. Results of this study add to the growing body of literature showing that, with improvement of analytics, WGS data could be used to predict antimicrobial susceptibility.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Ferreira I, Beisken S, Lueftinger L, et al. Species Identification and Antibiotic Resistance Prediction by Analysis of Whole-Genome Sequence Data by Use of ARESdb: an Analysis of Isolates from the Unyvero Lower Respiratory Tract Infection Trial. J Clin Microbiol. 2020. PMID: 32295890. doi:10.1128/JCM.00273-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。